Clinical characteristics and outcome of SARS –CoV-2 infection in patients with cystic fibrosis managed at home

por Terlizzi, V., Francalanci, M., Taccetti, G.
Publicado 2022

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany

por Dolce, D., Ravenni, N., Francalanci, M., Campana, S., Camera, E., Mergni, G., Orioli, T., Cavicchi, M.C., Galici, V., Neri, A.S., Terlizzi, V., Taccetti, G.
Publicado 2021

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group

por Colombo, C., Alicandro, G., Daccó, V., Gagliano, V., Morlacchi, L.C., Casciaro, R., Pisi, G., Francalanci, M., Cavallo, A., Poli, P., Folino, A., Messore, B., Cristadoro, S., Leonetti, G., Maschio, M., Lucca, F., Cipolli, M.
Publicado 2021

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)

por Lucca, F., Carnovale, V., Casciaro, R., Comello, I., Daccò, V., Ferrara, E., Francalanci, M., Gramegna, A., Lucanto, M.C., Maschio, M., Messore, B., Pisi, G., Poli, P., Pradal, U., Rotolo, N., Salvatore, D., Vitullo, P., Cipolli, M.
Publicado 2022